MedMesh.i
Corpus
Accueil
Racine
Corpus
Exploration
Accueil
Racine
Accueil

Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Computer Simulation »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Computer Security < Computer Simulation < Confounding Factors, Epidemiologic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000133 (2020) Mohammed H. Shalayel ; Ghassab M. Al-Mazaideh ; Saleem H. Aladaileh ; Farhan K. Al-Swailmi ; Mohammad G. Al-ThiabatVitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
000270 (2021) Arif Ali ; Nasim Sepay ; Mohd Afzal ; Nayim Sepay ; Abdullah Alarifi ; M. Shahid ; Musheer AhmadMolecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19.
000339 (2021) Iram Iqbal Hejazi ; Md Amjad Beg ; Md Ali Imam ; Fareeda Athar ; Asimul IslamGlossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease.
000387 (2021) Giulia Fiscon ; Federica Conte ; Lorenzo Farina ; Paola PaciSAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
000851 (2020) Woon Yi Law ; Mohd Razip Asaruddin ; Showkat Ahamd Bhawani ; Samsur MohamadPharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
000887 (2021) C N Prashantha ; K. Gouthami ; L. Lavanya ; Sivaramireddy Bhavanam ; Ajay Jakhar ; R G Shakthiraju ; V. Suraj ; K V Sahana ; H S Sujana ; N M Guruprasad ; R. RamachandraMolecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
000A79 (2020) Ravishekar Kannan ; Andrzej PrzekwasA multiscale absorption and transit model for oral delivery of hydroxychloroquine: Pharmacokinetic modeling and intestinal concentration prediction to assess toxicity and drug-induced damage in healthy subjects.
000A84 (2020) John P A. IoannidisGlobal perspective of COVID-19 epidemiology for a full-cycle pandemic.
000C13 (2021) Eleni Karatza ; George Ismailos ; Markos Marangos ; Vangelis KaralisOptimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics: a review of the literature and simulations.
000C38 (2020) Katarina Barali ; Dragica Jorgovanovi ; Katarina Živan Evi ; Evica Antonijevi Miljakovi ; Biljana Antonijevi ; Aleksandra Buha Djordjevic ; Marijana Ur I ; Danijela Uki OsiSafety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.
000C86 (2020) Thakur Uttam Singh ; Subhashree Parida ; Madhu Cholenahalli Lingaraju ; Manickam Kesavan ; Dinesh Kumar ; Raj Kumar SinghDrug repurposing approach to fight COVID-19.
000F12 (2020) Gaurav S. Dave ; Kalpna D. Rakholiya ; Mital J. Kaneria ; Bhemji P. Galvadiya ; Sudhanshu R. Vyas ; Vaktabhai H. Kanbi ; Manubhai P. PatelHigh affinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection.
000F52 (2020) Ulf Norinder ; Astrud Tuck ; Kalle Norgren ; Vesna Munic KosExisting highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
000F71 (2020) Rujuta R. Deshpande ; Arpita Pandey Tiwari ; Narendra Nyayanit ; Manisha ModakIn silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2.
001279 (2020) Joseph T. Ortega ; Maria Luisa Serrano ; Beata JastrzebskaClass A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.
001368 (2021) Pauline Thémans ; Nicolas Dauby ; Loïc Schrooyen ; Faustine Lebout ; Marc Delforge ; Rakan Nasreddine ; Agnès Libois ; Marie-Christine Payen ; Déborah Konopnicki ; Francoise Wuillaume ; Cecile Lescrainier ; Veerle Verlinden ; Jean-Michel Dogné ; Jamila Hamdani ; Flora T. MusuambaModel informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Computer Simulation" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Computer Simulation" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Computer Simulation
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021